Roivant Sciences
ROIV
111 hedge funds and large institutions have $3.29B invested in Roivant Sciences in 2022 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 10 closing their positions.
330% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 10
228% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $876K
176% more capital invested
Capital invested by funds: $1.19B → $3.29B (+$2.1B)
131% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 16
120% more funds holding in top 10
Funds holding in top 10: 5 → 11 (+6)
42% more funds holding
Funds holding: 78 → 111 (+33)
4.13% more ownership
Funds ownership: 52.66% → 56.79% (+4.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$146M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$29.5M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$16.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.5M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$38.1M |
| 2 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$24.2M |
| 3 |
PT
Palantir Technologies
Aventura,
Florida
|
-$5.85M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.17M |
ROIV Hedge Fund Activity: Q4 2022 in Review
111 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q4 2022, worth a combined $3.29B — up 176% from $1.19B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new ROIV positions and 10 closed out — a net gain of 33 holders — while 37 added to existing stakes and 16 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was QVT Financial, cutting an estimated $38.1M.
- 111 institutional investors held Roivant Sciences (ROIV) as of Q4 2022, up from 78 in Q3 2022.
- Funds reported $3.29B of Roivant Sciences stock for Q4 2022, up 176% quarter-over-quarter.
- 43 funds opened new Roivant Sciences positions in Q4 2022 and 10 closed out, a net change of +33 holders.
- The largest Roivant Sciences buyer in Q4 2022 was Fidelity Investments, an estimated $146M added.
- The largest Roivant Sciences seller in Q4 2022 was QVT Financial, an estimated $38.1M sold.
Based on aggregated 13F filings for Q4 2022.